cerebrolysin
Jump to navigation
Jump to search
Introduction
- neuroeptide mixture from purified brain extracts by enzymatic breakdown
- porcine-derived collection of growth factors[5]
Function
- has nerve growth factor like activity on DRG neurons
Indications
Dosage
- 30 mL/day cerebrolysin intravenous infusion with 0.9% saline
- administered for 30 days over a 3 month perior
Mechanism of action
- unknown, effects may be longer lasting than drug itself[1]
- may inhibit apoptosis[2]
- induces expression of blood brain barrier glucose transporter expression[3]
- improves synaptic plasticity & behavioral performance in a mouse model for Alzheimer's disease[4]
More general terms
Additional terms
References
- ↑ Jump up to: 1.0 1.1 Crook TH et al, Effects of N-PEP-12 on memory among older adults In Clin Psychoparmacol 2005, 20:97 PMID: https://www.ncbi.nlm.nih.gov/pubmed/15729085
- ↑ Jump up to: 2.0 2.1 Deigner HP et al, Apoptosis modulators in the therapy of neurodegenerative diseases. Expert Opin Investig Drug 2000, 9:747 PMID: https://www.ncbi.nlm.nih.gov/pubmed/11060707
- ↑ Jump up to: 3.0 3.1 Windisch M Approach towards an integrative drug treatment of Alzheimer's disease. J Neural Transm Suppl 2000, 59:301 PMID: https://www.ncbi.nlm.nih.gov/pubmed/10961442
- ↑ Jump up to: 4.0 4.1 Rockenstein E et al, Effects of Cerebrolysin on neurogenesis in an APP transgenic mouse model of Alzheimer's disease. Acta Neuropathol (Berl) 2007, 113:265 PMID: https://www.ncbi.nlm.nih.gov/pubmed/17131129
- ↑ Jump up to: 5.0 5.1 5.2 Bosworth T Old Drug a New Option for Stroke-Related Aphasia? Mesdcape.Oct 28, 2024 https://www.medscape.com/viewarticle/old-drug-new-option-stroke-related-aphasia-2024a1000jn5